WegovyBellevue, WA

Wegovy in Bellevue, WA

On the West Coast, Bellevue, Washington residents have many health-conscious options. Wegovy® is the FDA-approved Injectable pen Semaglutide product manufactured by Novo Nordisk, approved since 2021. Weight Method offers a separate telehealth program: licensed Washington providers evaluate eligible patients and prescribe compounded Semaglutide, dispensed by a U.S.-licensed 503A pharmacy. Compounded Semaglutide is not FDA-approved. The Weight Method program for Bellevue starts at $199/month, including the provider evaluation, the medication, ongoing care, and home delivery.

GLP-1 treatment prescribed by licensed providers. Delivered to your door.

Take the Free Quiz

Free consultation · No commitment · Results in weeks

Patient
Patient
Patient
Patient
Patient
4.9/5

From 2,000+ patients · Bellevue is already seeing results

Licensed Providers
FDA-Approved Medications
Free Shipping
HIPAA Compliant
Updated June 2026Medically reviewed by licensed providers

GLP-1 weight-loss treatment available to eligible patients in Bellevue, WA. Weight Method offers compounded semaglutide, prescribed by licensed providers, from $199/month with virtual consultations and direct-to-door shipping.

How does this medication work for weight loss?

Wegovy® by Novo Nordisk is the FDA-approved Injectable pen Semaglutide product, taken Once weekly and approved in 2021 for Chronic weight management. Semaglutide works by mimicking incretin hormones that regulate hunger and satiety, reducing appetite and helping you feel full with smaller portions. Weight Method is a separate telehealth program for Bellevue residents: licensed providers evaluate eligible patients and prescribe compounded Semaglutide, dispensed by a U.S.-licensed 503A pharmacy. Compounded Semaglutide is not FDA-approved. The Weight Method program starts at $199/month and includes the provider evaluation, the medication, ongoing care, and home delivery.

What treatment options are available locally?

In a fast-moving city like Bellevue, time is the scarcest resource. Wegovy® is the FDA-approved Injectable pen Semaglutide product by Novo Nordisk, taken Once weekly. Weight Method's separate program prescribes compounded Semaglutide, dispensed by a U.S.-licensed 503A pharmacy, at $199/month with no recurring clinic visits — your medication arrives at your Bellevue address, and virtual check-ins happen on your schedule. Compounded Semaglutide is not FDA-approved.

Ready to Get Started?

Answer a few quick questions to see if you qualify.

Check Eligibility

Your Treatment Options

Compounded GLP-1 medications dispensed by U.S.-licensed 503A pharmacies.

Starting at$199/mo
Semaglutide
Most PopularIn Stock

Semaglutide

Compounded semaglutide. Once-weekly subcutaneous injection.

  • Weekly injection
  • Gradual dose increase
  • Provider monitoring
  • Free shipping
Check Eligibility
Tirzepatide
In Stock

Tirzepatide

Compounded tirzepatide. Dual-action GLP-1/GIP, once-weekly subcutaneous injection.

  • Weekly injection
  • Dual hormone action
  • Provider monitoring
  • Free shipping
Check Eligibility

Frequently Asked Questions

No. Weight Method operates on a direct-pay model with transparent pricing. The compounded Semaglutide program starts at $199/month and covers your medication, provider consultations, and free delivery to Bellevue. No insurance claims, no prior authorizations, and no surprise bills. Compounded Semaglutide is dispensed by a U.S.-licensed 503A pharmacy and is not FDA-approved.

Wegovy® is a Injectable pen manufactured by Novo Nordisk, FDA-approved since 2021 for Chronic weight management. It contains Semaglutide, which mimics natural incretin hormones to reduce appetite, slow gastric emptying, and help your body regulate hunger. Wegovy® is taken Once weekly. Weight Method does not sell Wegovy®; we are a separate program that prescribes compounded Semaglutide starting at $199/month (dispensed by a U.S.-licensed 503A pharmacy and not FDA-approved).

Yes. Weight Method's licensed providers in Washington can prescribe compounded Semaglutide through a fully virtual process. You complete an online health assessment, have a virtual consultation, and if approved, your compounded Semaglutide is shipped directly to your Bellevue address. Compounded Semaglutide is dispensed by a U.S.-licensed 503A pharmacy and is not FDA-approved. There is no need to visit a physical clinic, and the program starts at $199/month.

Wegovy® is the FDA-approved Injectable pen Semaglutide product manufactured by Novo Nordisk. Weight Method prescribes compounded Semaglutide, which is prepared by a U.S.-licensed 503A compounding pharmacy under state and federal pharmacy regulations. Compounded Semaglutide is not FDA-approved and is a different regulatory category from FDA-approved finished drug products. Your Weight Method provider will discuss whether compounded Semaglutide is an appropriate option based on your medical history.

Weight Method's compounded Semaglutide program starts at $199/month in Bellevue. That price includes the medication, licensed provider consultations, and free home delivery. We don't bill insurance — there are no copays, no prior authorizations, and no surprise charges. Compounded Semaglutide is dispensed by a U.S.-licensed 503A pharmacy and is not FDA-approved. Wegovy® is a separate FDA-approved Injectable pen Semaglutide product manufactured by Novo Nordisk; its retail price varies by pharmacy.

Start Your Treatment

Consult with a licensed provider in Washington and start Wegovy from $199/month.

Get Started Now

Free consultation. No commitment.

Other Brands in Bellevue

Nearby Cities

See More